Exciting News from Yazen Health
We are thrilled to announce that Martin Carlsson, Associate Professor, Endocrinologist, Chief Medical Officer and founder of Yazen health, recently contributed to a dynamic roundtable debate hosted by Health Tech World.The discourse revolves around the current landscape and future trajectory of digital health. As pioneers in the field, we are proud to be at the forefront of this transformative journey.Digital health has already made significant strides, reshaping outcomes globally. For example; the NHS (UK) has added that digital delivery is crucial for the treatment of overweight and obesity in its NICE guidelines. Care via a digital platform is both more efficient and convenient for the patient which in turn leads to a better outcomes. Martin Carlsson, with his expertise and insights, explore how clinicians, innovators, and developers can further elevate success in 2024 and beyond.
Watch the roundtable on YouTube here: https://www.youtube.com/watch?v=HlDKFjkO87A
More news
WOD26: Data Reveals Persistent Shame & Stigma Around Obesity Treatment
Ahead of World Obesity Day on 4 March, Yazen is sharing new findings from internal patient data, revealing that shame and stigma remain major barriers to obesity care — even as effective medical treatments become more widely available.
Yazen achieved record-breaking growth in 2025, doubling its revenue.
In 2025, Yazen's revenue surged 87% to nearly €29.4 million, with gross profits doubling to €16.5 million. Now treating over 37,000 active patients across seven countries, the company is eyeing further expansion into two more markets in 2026. Despite an EBITDA of –€5.7 million due to heavy growth investment, Yazen remains a leader in European obesity care.
